PaulJTuiteMD

PubMed

• 3 citations
  White matter microstructure in Parkinson's disease with and without elevated rapid eye movement sleep muscle tone.
  Rémi Patriat, Pramod K Pisharady, Sommer Amundsen-Huffmaster, Maria Linn-Evans, Michael Howell, Jae Woo Chung, Matthew N Petrucci, Aleksandar Videnovic, Erin Holker, J...> ;Brain Communications. 2022 Jan 1
• 9 citations
  Semi-automated approaches to optimize deep brain stimulation parameters in Parkinson's disease.
  Kenneth H. Louie, Matthew N. Petrucci, Logan L. Grado, Chiahao Lu, Paul J. Tuite, Andrew Lamperski, Colum D. MacKinnon, Scott E. Cooper, Theoden I. Netoff> ;Journal of Neuroengineering and Rehabilitation. 2021 May 21
• 6 citations
  Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson's Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T.
  Xiao Hong Zhu, Byeong Yeul Lee, Paul J. Tuite, Lisa D. Coles, Abhishek G. Sathe, Chi Chen, Jim Cloyd, Walter C. Low, Clifford J. Steer, Wei Chen> ;Metabolites. 2021 Mar 1
• 6 citations
  REM Sleep Without Atonia and Gait Impairment in People with Mild-to-Moderate Parkinson's Disease.
  Sommer L Amundsen-Huffmaster, Matthew N. Petrucci, Maria E. Linn-Evans, Jae Woo Chung, Michael J. Howell, Aleksandar Videnovic, Paul J. Tuite, Scott E. Cooper, Colum D...> ;Journal of Parkinson's Disease. 2021 Jan 1
• 23 citations
  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
  Brent Bluett, Alexander Pantelyat, Irene Litvan, Farwa Ali, Diana Apetauerova, Danny Bega, Lisa Bloom, James H. Bower, Adam L. Boxer, Marian L. Dale, Rohit Dhall, Anto...> ;Frontiers in Neurology. 2021 Jul 1
• 11 citations
  REM sleep without atonia is associated with increased rigidity in patients with mild to moderate Parkinson's disease.
  Maria E. Linn-Evans, Matthew N. Petrucci, Sommer L. Amundsen Huffmaster, Jae Woo Chung, Paul J. Tuite, Michael J. Howell, Aleksandar Videnovic, Colum D. MacKinnon> ;Clinical Neurophysiology. 2020 Aug 1
• 20 citations
  Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease—A Pilot Study
  Abhishek G. Sathe, Paul J. Tuite, Chi Chen, Yiwei Ma, Wei Chen, James C. Cloyd, Walter C. Low, Clifford J. Steer, Byeong Yeul Lee, Xiao Hong Zhu, Lisa D. Coles> ;Journal of Clinical Pharmacology. 2020 Jun 1
• 9 citations
  Hatha yoga training improves standing balance but not gait in Parkinson's disease.
  Naveen Elangovan, Corjena Cheung, Arash Mahnan, Jean F Wyman, Paul Tuite, Jürgen Konczak> ;Sports Medicine and Health Science. 2020 Jun 1
• 4 citations
  Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy.
  Reena V. Kartha, James M. Joers, Marcia R. Terluk, Abigail Travis, Kyle Rudser, Paul J. Tuite, Neal J. Weinreb, Jeanine Jarnes, James C. Cloyd, Gülin Öz> ;Journal of Inherited Metabolic Disease. 2020 May 1
• 13 citations
  GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies
  Parker H. Johnson, Neal J. Weinreb, James C. Cloyd, Paul J. Tuite, Reena V. Kartha> ;Molecular Genetics and Metabolism. 2020 Feb 1
• 7 citations
  The Transition from Standing to Walking Is Affected in People with Parkinson's Disease and Freezing of Gait.
  Sommer L. Amundsen Huffmaster, Chiahao Lu, Paul J. Tuite, Colum D. MacKinnon> ;Journal of Parkinson's Disease. 2020 Jan 1
• 18 citations
  Motor phenotype classification in moderate to advanced PD in BioFIND study
  Lan Luo, Howard Andrews, Roy N. Alcalay, Fernanda Carvalho Poyraz, Amelia K. Boehme, Jennifer G. Goldman, Tao Xie, Paul J. Tuite, Claire Henchcliffe, Penelope Hogarth,...> ;Parkinsonism & Related Disorders. 2019 Jun 23
• 90 citations
  Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
  Adam L. Boxer, Irfan Qureshi, Michael K. Ahlijanian, Michael Grundman, Lawrence I. Golbe, Irene Litvan, Lawrence S. Honig, Paul J. Tuite, Nikolaus R. McFarland, Padrai...> ;The Lancet. Neurology. 2019 Jun 1
• 6 citations
  McLeod syndrome: Five new pedigrees with novel mutations
  Joshua Weaver, Harini Sarva, Daniel A. Barone, Sarah M. Bobker, Khalaf Bushara, Amie L. Hiller, Makoto Ishii, Joseph Jankovic, Shenela Lakhani, K. Niotis, D.W. Scharre...> ;Parkinsonism & Related Disorders. 2019 May 2
• 18 citations
  Somatosensory Training Improves Proprioception and Untrained Motor Function in Parkinson's Disease.
  Naveen Elangovan, Paul J. Tuite, Jürgen Konczak> ;Frontiers in Neurology. 2018 Dec 10
• 10 citations
  White matter measures correlate with essential tremor severity-A pilot diffusion tensor imaging study.
  Igor Nestrasil, Alena Svátková, Kyle Rudser, Ravishankar Chityala, Amy Wakumoto, Bryon A. Mueller, Petr Bednařík, Paul J. Tuite, Xiang Wu, Khalaf Bushara> ;Brain and Behavior. 2018 Jul 2
• 28 citations
  The effects of anodal tDCS over the supplementary motor area on gait initiation in Parkinson’s disease with freezing of gait: a pilot study
  Chiahao Lu, Sommer L. Amundsen Huffmaster, Paul J. Tuite, Colum D. MacKinnon> ;Journal of Neurology. 2018 Jun 28
• Corrigendum: Multi-modal Brain MRI in Subjects with PD and iRBD.
  Silvia Mangia, Alena Svátková, Daniele Mascali, Mikko J. Nissi, Philip C. Burton, Petr Bednarik, Edward J. Auerbach, Federico Giove, Lynn E. Eberly, Michael J. Howell,...> ;Frontiers in Neuroscience. 2018 Jun 26
• 35 citations
  Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial.
  Corjena Cheung, Rozina Bhimani, Jean F. Wyman, Jürgen Konczak, Lei Zhang, Usha Mishra, Marcia R. Terluk, Reena V. Kartha, Paul J. Tuite> ;Pilot and Feasibility Studies. 2018 Oct 23
• 98 citations
  Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
  Jennifer G. Goldman, Howard Andrews, Amy W. Amara, Anna Naito, Roy N. Alcalay, Leslie M. Shaw, Peggy Taylor, Tao Xie, Paul J. Tuite, Claire Henchcliffe, Penelope Hogar...> ;Movement Disorders. 2018 Feb 1
• 91 citations
  Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
  Lisa D. Coles, Paul J. Tuite, Gülin Öz, Usha Mishra, Reena V. Kartha, Kathleen M. Sullivan, James C. Cloyd, Melissa Terpstra> ;Journal of Clinical Pharmacology. 2018 Feb 1
• 10 citations
  Multi-modal Brain MRI in Subjects with PD and iRBD.
  Silvia Mangia, Alena Svátková, Daniele Mascali, Mikko J. Nissi, Philip C. Burton, Petr Bednarik, Edward J. Auerbach, Federico Giove, Lynn E. Eberly, Michael J. Howell,...> ;Frontiers in Neuroscience. 2017 Dec 19
• 30 citations
  Effect of Cue Timing and Modality on Gait Initiation in Parkinson Disease With Freezing of Gait.
  Chiahao Lu, Sommer L. Amundsen Huffmaster, Paul J. Tuite, Jacqueline M. Vachon, Colum D. MacKinnon> ;Archives of Physical Medicine and Rehabilitation. 2017 Jul 1
• 12 citations
  Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)
  Paul J. Tuite> ;Brain Sciences. 2017 Jun 16
• 19 citations
  Magnetic resonance imaging as a potential biomarker for Parkinson's disease
  Paul J. Tuite> ;Translational Research. 2016 Sep 1
• Join now to see all

Journal Articles

• Impulsive behavior and associated clinical variables in Parkinson’s disease.  
  Abosch A, Gupte A, Eberly LE, Tuite PJ, Nance M, Grant JE, Psychosomatics
• A recommended scale for cognitive screening in clinical trials of Parkinson’s disease.  
  Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Troster AI, Uc EY, Mov Disord 25:2501-7
• Cancer incidence in a trial of an antiapoptotic agent for Parkinson’s disease.  
  Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I; PSG PRECEPT Investigators (Tuite P; UM Site Investigator), Hyson C, Oakes D, Flagg..., Mov Disord 25:1801-8, 1992-8
• Parkinson Study Group-PROGENI Investigators (Tuite P; UM Site Investigator) Maternal inheritance and mitochondrial DNA variants in familial Parkinson’s disease.  
  Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T, BMC Med Genet 11:53
• The effect of dopamine replacement therapy on haptic sensitivity in Parkinson’s disease.  
  Li KY, Pickett K, Nestrasil I, Tuite P, Konczak J, J Neurol 257:1992-8
• A long-term study of istradefylline in subjects with fluctuating Parkinson’ disease.  
  Factor S, Mark MH, Watts R, Struck L, Mori A, Ballerini R, Sussman NM, Parkinsonism Relat Disord 16:423-6
• T1rho and T2rho MRI in the evaluation of Parkinson’s disease.  
  Nestrasil I, Michaeli S, Liimatainen T, Rydeen CE, Kotz CM, Nixon JP, Garwood M, Hanson T, Tuite PJ, J Neurol 257:964-8
• Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial.  
  Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM, Parkinsonism Relat Disord 16:16-20
• A comparison of treatment thresholds in two large Parkinson’s disease clinical trial cohorts.  
  Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I, Mov Dis 24(16):2370-2378
• PROGENI Investigators, Coordinators and Molecular Genetic Laboratories; GenePD Investigators, Coordinators and Molecular Genetic Laboratories (Tuite P; UM Site Investi...  
  Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T, BMC Med Genet 22;10:98
• A longitudinal program for biomarker development in Parkinson disease: a feasibility study.  
  Ravina B, Tanner C, DiEuliis D, Eberly S, Flagg E, Galpern W, Fahn S, Goetz C, Grate S, Kurlan R, Lang A, Marek K, Kieburtz, Oakes D, Elliott R, Shoulson I, and the Pa..., Mov Disord 24:2081-90
• Mutations in GBA are associated with familial Parkinson diseas susceptibility and age at onset.  
  Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T, Parkinson Study Group-PROGENI Investigators Inv..., Neurology 72(4):310-6
• Genomewide association study for susceptibility genes contributing to familial Parkinson disease.  
  Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH, Coordinators and Molecular Genetic Laborato..., Hum Genet 124(6):593-605
• Variation in GIGYF2 is not associated with Parkinson disease.  
  Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T, Neurology 72:1886-92
• Long-term outcome of early versus delayed rasagiline treatment in early Parkinson’s disease.  
  Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Mov Disord 2009 24:564-73
• Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.  
  Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC, Parkinson Study Group-PROGENI Investigators (Tuite P; UM Site ..., Neurology 73:279-86
• Haptic perception of object curvature in Parkinson’s disease.  
  Konczak J, Li KY, Tuite PJ, Poizner H, PLoS ONE 2008;3(7):e2625
• Clinical correlates of depressive symptoms in familial Parkinson’s disease  
  Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T, Parkinson’s Study Group-PROGENI Investigators (Tuite P; UM Site Investigator), disease Mov Disord 23(15):2216-2223
• Fatigue in levodopa-naïve subjects with Parkinson’s disease.  
  Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S, Parkinson Study Group ELLDOPA Investigators (Tuite P; UM Site Investigator), Neurology 71:481-5
• Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.  
  22. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A and the Parkinson Study Group PRECEPT Investigators (Tuite P; UM Site Inves..., Arch Neurol 65:716-723
• Reversible cortical blindness (Anton’s syndrome) associated with bilateral occipital EEG abnormalities.  
  Roos KL, Tuite P, Below ME, Pascuzzi RM, Clin Electroencephalogr 21:104-109
• Cerebral vein thrombosis due to hereditary antithrombin III deficiency.  
  Tuite P, Ahmad F, Grant I, Stewart JD, Carpenter S, Ethier R, Can J Neurol Sci 20: 158-161
• Dopa-responsive Parkinsonism phenotype of Machado-Joseph disease - confirmation of 14q CAG expansion.  
  Tuite P, Rogaeva EA, St George-Hyslop PH, Lang AE, Neurol 38: 684-687
• Idiopathic generalized myokymia (Isaacs’s syndrome) with hand posturing resembling dystonia.  
  Tuite P, Navarette C, Bril V, Lang AE, Mov Disord 11: 448-449
• Atypical dopa-responsive Parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease.  
  Tuite P, Provias JP, Lang AE, Journal Neurol Neurosurg Psychiatry 61: 523-527
• Join now to see all

Books/Book Chapters

•  
  Tuite P, Thomas C, Ruekert L, Fernandez HEditors: Springer Publishing.
•  
  Tuite PEditors: Galvez-Jimenez N and Tuite P.Cambridge Press
•  
  Chapter: Ironing out the details 
  Bower M and Tuite PEditors: Hubert Fernandez and Marcelo Merello. Demos Medical.
•  
  Chapter: Neurodegeneration with brain iron accumulation 
  Bower M and Tuite PEditors: N Galvez-Jimenez and P Tuite.
•  
  Tuite P
•  
  Chapter: New treatment modalities in Parkinson’s Disease 
  Tuite P, Riss J and Brauer LHEditors: Nestor Galvez-Jimenez.Parthenon Publishing, Abingdon, UK
•  
  Chapter: Chapter 14: Tolcapone 
  Tuite P and Weisenberg BEditors: Rajesh Pahwa, MD, Kelly Lyons, PhD, and William C. Koller, MD.Marcel Dekker , New York
•  
  Chapter: Syndromes of Disordered Posture and Movement 
  Tuite P and Lang A EEditors: Bruce Berg.McGraw Hill
• Join now to see all

Abstracts/Posters

• Ugurbil. Assessment of brain iron and a neuronal marker in patients with Parkinson’s disease using novel MRI contrasts.
  Tuite, P, Michaeli S, Sorce D, Oz G, Garwood M, International Movement Disorders Meeting, Kyoto, Japan
• Assessment of Brain Iron and a Neuronal Marker in Patients with Parkinson’s disease Using Novel MRI Contrasts Parkinson.
  Michaeli S, Sorce D, Oz G, Ugurbil K, Garwood M, Tuite, P, Study Group Meeting, PSG/MDS 20th Annual Symposia on Etiology, Pathogenesis and Treatment of Parkins, Chicago, IL.
• Multi-joint Kinanesthesia in Parkinson’s Disease.
  Li K., Tuite P, Poizner H, Konczak J, Society for Neuroscience, Georgia World Congress Center; Halls B3-B5
• Medicine & Pathology.
  Springer C.S., Ugurbil K., Tuite P., Garwood M. T1? and T1? Adiabatic Contrasts, Vivo Magnetic Resonance, Mount Holyoke College, South Hadley, MA
• Proton MRS of Bilateral Substantia Nigra in the Human Brain at 4 Tesla with Hadamard Encoding.
  Oz G, Terpstra M, Tkac I, Aia P, Lowary J, Tuite P, Grüetter R, ISMRM 14th Scientific meeting and exhibition, Seattle, WA
• The perception of heaviness in patients with Parkinson’s disease.
  Maschke M, Tuite P, Krawczewski K, Pickett K, Konczak J, PSG/MDS 19th Annual Symposia on Etiology, Pathogenesis and Treatment of Parkinson’s Disease, San Diego, CA
• Proton MR Spectroscopy of Substantia Nigra in the Human Brain at 4 Tesla.
  Oz G, Tuite P, Terpstra M, Tkac I, Aia P, Lowary J, Grüetter R, Eighteenth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease, Toronto, Ontario, Canada
• Weight Change after DBS Surgery.
  Thielen S, Tuite P, Third Annual Alfred F. Michael Medical Student Research Colloquium
• The North American survey of placement and adjustment techniques for deep brain stimulation.
  Ondo W, Tuite P, and others, American Academy of Neurology 56th Annual Meeting, San Francisco, California
• PARK3 and PARK6/7 Linked to Age of Onset of Parkinson Disease.
  Pankratz N., Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults CW, Conneally PM, Foroud T, and Parkinson Study Group (Tuite P, U of M Site Investigator), P02.073. Annual Meeting Program of the American Academy of Neurology, Honolulu, HA
• Lack of association of homozygosity for the 7048G7049 intron six Nurr1 gene polymorphism in 322 families with Parkinson disease. P04.043.
  Nichols WC, Pankratz N, Uniacke S, Reed T, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, and the Parkinson Study Group (Tuite P, U of M Site Investigator), Annual Meeting Program of the American Academy of Neurology, Honolulu, Hawaii
• Intracerebroventricular GDNF for advanced PD.
  Nutt J, et al (Tuite P, U of M Site Investigator), Presented at Annual Meeting Program of the American Academy of Neurology, Philadelphia, Pennsylvania
• Are CBGD and PSP Related? Clinical CBGD in Two Siblings: One with CBGD Pathology and the other with PSP Pathology.
  Tuite P, Malik RA, Knopman DS, Brent C, presented at the 51st Annual Meeting Program of the American Academy of Neurology, Toronto, Ontario, Canada
• Effects of bilateral stimulation on speech in Parkinson's disease.
  Solomon NP, McKee AS, Eriksen SK, Low WC, Maxwell RE, Tuite P, Annual Convention of the American Speech-Language-Hearing Association, San Antonio
• Pallidal Stimulation in 3 Parkinson's Disease Subjects.
  Tuite P, Movement Disorder Society meeting, New York
• GPI Stimulator Efficacy in PD Patient with Prior Contralateral Pallidotomy,” presented.
  Tuite P, Eleventh Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Sympos, San Diego, California
• Atypical Dopa-responsive Parkinsonism in a patient with megalencephaly, midbrain Lewy body disease and partial pathological features of Hallervorden-Spatz disease.
  Tuite P, Provias J, Lang AE, Fourth International Congress of Movement Disorders, Vienna, Austria
• Efficacy of the COMT inhibitor entacapone in the treatment of motor fluctuations in Parkinson’s disease.
  Tuite P, Sime AE, Lang AE, Fourth International Congress of Movement, Disorders, Vienna, Austria
• GPI Stimulator Efficacy in PD Patient with Prior Contralateral Pallidotomy,” presented.
  Tuite P, the 11th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and ..., San Diego, California
• Voxel-based morphometry and diffusion tensor imaging.
  Lehericy S, Luciana M, Kendi ATK, Ugurbil K, Tuite P, Parkinson’s disease. 21stAnnual Symposium on Etiology, Pathogenesis and ..., Washington, DC
• Ugurbil. Assessment of brain iron and a neuronal marker in patients with Parkinson’s disease using novel MRI contrasts.
  Tuite, P, Michaeli S, Sorce D, Oz G, Garwood M, Mov Disord 21(S15): S454
• Assessment of Brain Iron and a Neuronal Marker in Patients with Parkinson’s disease Using Novel MRI Contrasts.
  Michaeli S, Sorce D, Oz G, Ugurbil K, Garwood M, Tuite, P, Mov Disord 21(9):1545
• Baseline comparison of the PRECEPT and DATATOP clinical trial cohorts.
  Parkinson Study Group. (Tuite P, U of M Site Investigator, Mov Disord 21(Suppl 13):S121
• Identification of Risk Loci for Progressive Supranuclear Palsy.
  Hutton M, Coon K, Melquist S, Pearson J, Baker M, Craig DW, Dickson DW, Huentelman MJ, Tuite P, Bower M, Adamson JL, Crook R, Stephan D, Society for Neuroscience
• A randomized controlled trial of etilevodopa in Parkinson’s disease patients with motor fluctuations.
  Parkinson Study Group (Schwid S, presenter) (Tuite P, U of M Site Investigator), Mov Disord 20(9):1237
• Join now to see all

Lectures

• Parkinson’s disease update for neurologists in Willmar. 
  Minnesota
• Outreach to Duluth neurologists with lecture on Parkinson’s Disease. 
• Parkinson’s disease patient event. 
  Duluth, MN
• Presentation on imaging in Parkinson’s disease at the 2008 Minnesota Aging Retreat. 
  Minneapolis, MN
• Physical, Occupational and Speech Therapist presentation. 
  Radisson, Minneapolis, Minnesota
• Lecture on Medical, Surgical, and Emotional Care for the treatment. 
  Parkinson’s disease at APDA Conference,Minneapolis, Minnesota
• Panelist: Physical Changes Associated with Parkinson’s disease. 
  2nd Annual Young-onset Parkinson Network conference, Bloomington, Minnesota
• Movement Disorders in the Elderly. 
  Medical School Faculty Presentation, Minneapolis, Minnesota
• Headache. 
  Presented at the CME course on "Practical Solutions for Your Chronic Patients" Symposium, Minneapoli
• Fitting New Drugs Into Disease States: Parkinson's Disease. 
  Continuing Education in Pharmacy, University of Minnesota
• Staying on the Job with Parkinson’s disease. 
  H.J. Cummins Star Tribune Article on Work and Parkinson’s disease
• Sharing information on Parkinson’s disease from three author’s perspectives. 
  Minnesota
• Exploring Environmental Links to Disease: A Look at Parkinson’s disease and Non-Hodgkin’s Lymphoma Conference. 
  Sioux Falls, South Dakota
• Inservice lecture on movement disorders at end of life. 
  St. Joseph’s Hospital
• Parkinson’s disease update, seminar sponsored. 
  American Parkinson’s Disease Association, Twin Cities
• An Update on Parkinson’s Research. 
  The public Educational Conference on Parkinson’s disease
• Movement Disorders for healthcare professionals. 
  The Geritom Education Center
• Moderator for Research Strategies Session. 
  Scientists in Aging Research Retreat, Minneapolis, MN
• Geriatric Pharmacotherapy. 
  Parkinson’s disease
• Neurologic Devices. 
  Biomedical Engineering Institute,Chair
• Activa educational roundtable discussion on Innovative. 
  Theory and Technology for Activa Therapy
• Organization of Neuroimaging Symposium at the Center for MRI Research (CMRR) to discuss use of imaging for multiple sclerosis. 
  Parkinson’s disease, Huntington’s disease and other neurological conditions
• Clinical Neuroscience: Through the Lens of Technology. 
  Mini-Medical School
• Breakfast roundtable with TEVA. 
  Radisson Hotel, Minneapolis, Minnesota
• Health & the Life Sciences. 
  Evan Presentation to State Legislators on Parkinson’s disease during visit to UM
• Join now to see all

Other

• Parkinson’s disease program multiple talks and panel discussion. 
  Paul Joseph Tuite
  http://mnpdforum.roundtablelive.org/
• 30 minute TPT. 
  Paul Joseph Tuite, Channel 2 public TV
  TV program on Parkinson’s disease